European Finance News

DNO International ASA (OSL:DNO) : Third Quarter 2008 Results

🕔11/12/2008 5:01:00 PM

DNO International ASA (OSL:DNO) Oslo, 12 November, 2008: DNO International ASA (OSE:DNO) today announced its interim results for the third quarter and first nine months of 2008.

Read Full Article▸

Eitzen Chemical ASA (OSL:ECHEM) Eitzen Chemical - 3rd Quarter 2008 Results

🕔11/12/2008 5:01:00 PM

Eitzen Chemical ASA (OSL:ECHEM) Eitzen Chemical ASA (OSE: ECHEM) reports operating results of USD 17.4 million for the 3rd quarter, up 56% from the previous quarter. The 3rd quarter EBITDA was USD 38.9 million vs. USD 35.5 million in the 2nd quarter of 2008.

Read Full Article▸

OctoPlus N.V. (AMS:OCTO) OctoPlus Wins New Drug Delivery Evaluation Contract

🕔11/12/2008 4:47:00 PM

OctoPlus N.V. (AMS:OCTO) As part of the Company's recently announced strategic focus on developing controlled release formulations for clients, OctoPlus N.V. ("OctoPlus" or "the Company") (Euronext: OCTO) announces today that it has signed a new drug delivery technology evaluation contract with a US-based biotech company.

Read Full Article▸

Komplett ASA (OSL:KOM) KOM - MANDATORY NOTIFICATION OF TRADE

🕔11/12/2008 4:33:01 PM

Komplett ASA (OSL:KOM) Ole Sauar, a primary insider in Komplett ASA, has on 11 November 2008 bought 12,400 Komplett shares at a price of 29.18 NOK each. After this transaction Mr. Sauar holds 432,444 shares in Komplett ASA

Read Full Article▸

Imtech N.V. (AMS:IM) Imtech Shores Up ICT Portfolio In Germany

🕔11/12/2008 4:33:00 PM

Imtech N.V. (AMS:IM) GOUDA - Imtech (technical services provider in Europe) has acquired German ICT specialist Neo GmbH. With its 45 employees, Neo realised revenues of 4 million euro in 2007. Neo is being integrated into Imtech's German ICT division, to augment Imtech's ICT portfolio in Germany. The management of Neo will stay on after the acquisition, thus guaranteeing continuity.

Read Full Article▸

ING Group (AMS:INGB) ING Reports Underlying Net Loss Of EUR 585 Million In 3Q

🕔11/12/2008 4:33:00 PM

ING Group (AMS:INGB) * Underlying net loss of EUR 585 million driven by crisis in the financial markets

Read Full Article▸

Pronova BioPharma ASA (OSL:PRON) Pronova BioPharma Share Buy Back

🕔11/12/2008 4:03:01 PM

Pronova BioPharma ASA (OSL:PRON) Pronova BioPharma ASA (OSE: PRON.OL) ("Pronova BioPharma" or the "company") has on 11 November 2008 purchased 37 000 of its own shares in the market at a price of NOK 19,95 per share and intends to purchase an additional 141 000 shares in the market. After this transaction, the company holds 59 000 shares. Pronova BioPharma ASA has entered into an agreement to sell 200 000 of the company's shares to Per-Oluf Olsen, who will take over as CEO of the company after Tomas Settevik. This sale will be effected once Per-Oluf Olsen has assumed the position of CEO. Following the completion of these transactions, Pronova BioPharma ASA will not hold any of its own shares.

Read Full Article▸